Dergiler / Anadolu Kardiyoloji Dergisi / 2014 / Cilt: 14 - Sayı: 6

Association of omentin Val109Asp polymorphism with coronary artery disease

Sayfa
511–514
Yayın Tarihi
2022-10-10
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

In conclusion, it may be speculated that Val/Val genotype increases the tendency for CAD, but this experimentshould done with larger population to clarify this issue.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Objective: Coronary artery disease (CAD) is the most important morbidity and mortality disease in the world.
📊
Temel Bulgular & Veri:The aim of this study is to investigatethe relationship between omentin Val109Asp polymorphism and CAD.Methods: This is an observational study on genetic association. 157 consecutive patients who had undergone coronary angiography wereincluded in the study.
💡
Sonuç & Katkı:In conclusion, it may be speculated that Val/Val genotype increases the tendency for CAD, but this experimentshould done with larger population to clarify this issue.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Abstract

Objective: Coronary artery disease (CAD) is the most important morbidity and mortality disease in the world. It is also one of the leading causesof death in Turkey. Omentin, a recently found adipocytokine, is reported to regulate insulin sensitivity. It has anti-inflammatory properties and isinversely associated with CAD. Omentin gene polymorphism in patients with CAD has not been studied yet. The aim of this study is to investigatethe relationship between omentin Val109Asp polymorphism and CAD.Methods: This is an observational study on genetic association. 157 consecutive patients who had undergone coronary angiography wereincluded in the study. Seventy-five of them had CAD and the rest serves the control group. Val109Asp polymorphism was analyzed and com-pared. Chi-square test was used in comparison of genotype frequencies, whereas ANOVA and chi-square tests were used in comparison ofclinical characteristics according to the genotypes.Results: There was no significant difference between CAD patients and control subjects regarding omentin Val109Asp polymorphism. However, a 2.5fold increase in Val/Val (homozygous mutant) genotype was detected in patients with CAD. The OR (80% Cl) for Val/Val genotype was 3.46 (1.14-10.49).Conclusion: Although no significant difference was detected regarding omentin Val109Asp polymorphism, Val/Val genotype frequency was found to bemore in patient group than control group. In conclusion, it may be speculated that Val/Val genotype increases the tendency for CAD, but this experimentshould done with larger population to clarify this issue.

🔖

Bu Makaleye Atıf Yap

YÖRÜK, Ü., YAYKAŞLI, K. O., ÖZHAN, H., MEMİŞOĞULLARI, R., KARABACAK, A., BULUR, S., ASLANTAŞ, Y., BAŞAR, C., KAYA, E. (2022). Association of omentin Val109Asp polymorphism with coronary artery disease. Anadolu Kardiyoloji Dergisi, Cilt: 14 - Sayı: 6, 511–514. https://ajindex.com/articles/436019

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (12)

  1. Go AS, Mozaffarian D, Roger VL, Benjamin EJ, Berry JD, Borden WB, et al. American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics-2013 update: a report from the American Heart Association. Circulation 2013
  2. e6-e245. [CrossRef] 2. Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 2005
  3. [CrossRef] 3. Miyoshi T, Doi M, Hirohata S, Sakane K, Kamikawa S, Kitawaki T, et al. Cardio-ankle vascular index is independently associated with the severity of coronary atherosclerosis and left ventricular function in patients with ischemic heart disease. J Atheroscler Thromb 2010
  4. [CrossRef] 4. Kajiya M, Miyoshi T, Doi M, Usui S, Iwamoto M, Takeda K, et al. Serum adipocyte fatty acid-binding protein is independently associated with complex coronary lesions in patients with stable coronary artery disease. Heart Vessels 2013
  5. [CrossRef] 5. Yaykasli KO, Dogan M, Kaya E, Ozsahin M, Yaykasli E, Ataoglu S, Yuce H. The upregulation of matrix metalloproteinase-2 and -9 genes caused by resistin in human chondrocytes, Acta Medica Anatolia 2014
  6. 2(1): 19-23. [CrossRef] 6. Fukuhara A, Matsuda M, Nishizawa M, Segawa K, Tanaka M, Kishimoto K, et al. Visfatin: a protein secreted by visceral fat that mimics the effects of insulin. Science 2005
  7. [CrossRef] 7. Alçelik A, Tosun M, Özlü MF, Eroğlu M, Aktaş G, Kemahli E, et al. Serum levels of omentin in end-stage renal disease patients. Kidney Blood Press Res 2012
  8. [CrossRef] 8. Yang RZ, Lee MJ, Hu H, Pray J, Wu HB, Hansen BC, et al. Identification of omentin as a novel depot-specific adipokine in human adipose tissue: possible role in modulating insulin action. Am J Physiol Endocrinol Metab 2006
  9. E1253-61. [CrossRef] 9. Kralisch S, Klein J, Bluher M, Paschke R, Stumvoll M, Fasshauer M, et al. Therapeutic perspectives of adipocytokines. Expert Opin Pharmacother 2005
  10. [CrossRef] 10. Yang RZ, Shuldiner AR, Gong DW. Cloning of omentin, a new adipokine from human omental fat tissue. NCBI nucleotide database, 2003
  11. Accession Number: AY549722. 11. Zhong X, Zhang HY, Tan H, Zhou Y, Liu FL, Chen FQ, et al. Association of serum omentin-1 levels with coronary artery disease. Acta Pharmacol Sin 2011
  12. [CrossRef] 12. Shibata R, Ouchi N, Kikuchi R, Takahashi R, Takeshita K, Kataovka Y, et al. Circulating omentin is associated with coronary artery disease in men. A